GSK posts Phase 3b results for Bexsero booster; registers new bioavailability and UC trialsNov 6Weekly roundup, 7 itemsaletekitugbepirovirsenUpdated
GSK reports phase Ib data for Mo-Rez in platinum-resistant ovarian cancerOct 26Clinical readoutGlaxoSmithKlinemocertatug rezetecan
FDA grants accelerated approval to dostarlimab for rectal cancerOct 19Regulatory decisiondostarlimab-gxlyGlaxoSmithKline
GSK registers large new Shingrix cardiovascular trial; DESTINY HES study update postedOct 15Weekly roundup, 4 itemsdepemokimabdostarlimab-gxly
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
GSK posts bepirovirsen QT results; registers Mo-Rez ovarian, endometrial Phase 3 trialsJul 10Weekly roundup, 6 itemsbepirovirsencamlipixant